Sam Altman On Lex Fridman #419: Googler Employees React; Thoughts On GPT-5 & Elon’s Lawsuit| SVIC Podcast

By Jordan

In This Article:
    Add a header to begin generating the table of contents

    Secure your financial future with our free newsletter!

    Thank you for subscribing to the Silicon Valley Investors Club’s Newsletter – Investors Therapy!

    You will receive updates directly in your inbox.


    Google Employees React To Lex Fridman’s Interview With Sam Altman from Lex’s Love For Elon, Ilya’s Betrayal of Sam, GPT-5 Speculation, and How Sam Thinks People Should Use GPT-4. Show hosts Joe (Eng VP) and Jordan (M&A Deal Lead) worked at various companies from Google, Apple, Facebook, Microsoft, Salesforce, Slack, Carta, Splunk, Wealthfront, Adobe, Microsoft, and more.

    🤩Get access to new stories and blog posts for the episode and the ones we didn’t have time to cover, our book recommendations, exclusive episodes and latest AI research for only $5 at patreon.com/svic

    Chapters:
    00:00 Introduction and Reaction to Sam Altman Interview
    00:39 Sam Altman’s Depression And Dealing With Ilya’s Betrayal
    09:30 The Departure of the Anthropics Team & Their Hypocrisy
    14:40 The Importance of Trust and Loyalty
    16:30 OpenAI’s Old Board & AI Purity Rings
    23:25 Why You Need Non-Technical Board Members
    27:30 Sam Shut’s Down Lex Fridman
    28:21 Elon Musk’s Legal BS and Lex’s Love Affair
    33:05 How Lex Wants To Spoon With Elon
    35:00 Elon Being An Open Source Hypocrite
    39:00 Allin’s Crap Argument About OpenAI’s Tax Structure
    41:00 GPT-5 And Branding of GPTs
    46:00 How Sam Altman Thinks You Should Use GPT-4

    #ai #openai #chatgpt #samaltman #gpt4 #lexfridman #tesla #elonmusk #spacex #claude

    You May Also Like:

    Join our free newsletter for the latest SVIC blog posts and special commentary only for our newsletter subscribers.

    Join Investors Therapy Today!

    [blog_newsletter_subs_form]

    Join our free newsletter for the latest SVIC blog posts and special commentary only for our newsletter subscribers.

    Join Investors Therapy Today!

    [blog_newsletter_subs_form]

    You are being redirected to a third party site.

    We are redirecting you to one of our third party partners.